+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The safety of beta-propiolactone as a biologic sterilizing agent



The safety of beta-propiolactone as a biologic sterilizing agent



Angiology 12(2): 80-83



The article describes B-propiolactone as an unusual and much needed sterilizing agent for biological materials. The author gives his 9 years experience with the clinical limitations and the usefulness of the blood products and homotransplants sterilized with this agent. He also elaborates upon the objections being raised against the use of B-propiolactone because of its reported carcinogenic properties. The biological materials sterilized have shown no toxic, allergic or carcinogenic manifestations in animals, tissue culture or man. Even large transfusion volumes of treated plasma administered intravenously to man produced no ill effects. This is due to the fact that B-propio-lactone is completely degraded by the time the treated materials are used clinically and the small amounts of the degradation products are normal metabolites of body tissues. Clinically, a total of 2000 transfusions of treated plasma has been administered to 806 patients; over 300 patients have received arterial homografts, and at least 150 bone and 19 cartilage transplants have been performed. In none of these cases (followed over a period of 4 to 8 years) has any evidence been noted of carcinogenicity attributable to the B-propiolactone treated material.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 025928637

Download citation: RISBibTeXText


Related references

The safety of beta-propiolactone as a biologic sterilizing agent. Clinical evaluation with human plasma and homotransplants. Angiology 12: 80-83, 1961

The Safety of -Propiolactone as a Biologic Sterilizing Agent: Clinical Evaluation With Human Plasma and Homotransplants. Angiology 12(2): 80-83, 1961

Beta-propiolactone as sterilizing agent in collection of bone homo- and heterotransplants. Ortop Travmatol Protez 27(4): 53-56, 1966

Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations. Arzneimittel-Forschung 33(9): 1230-1231, 1983

Beta-propiolactone as a sterilizing agent in the preparation of homo- and heterologous bone transplants. Ortopediia Travmatologiia i Protezirovanie 27(4): 53-56, 1966

Analysis of beta-propiolactone by gas chromatography. I. A residue of beta-propiolactone in rabies vaccine. II. Hydrolysis of beta-propiolactone at pH 7.4. Journal of Chromatography 70(1): 128-134, 1972

Graft sterilization; a bacteriological and histological study of the relative merits of ethylene oxide and beta-propiolactone as tissue sterilizing agents, with special reference to arterial grafts. British Medical Journal 1(5073): 734-736, 1958

beta-Propiolactone as a toxoiding agent. Nature 182(4644): 1216-1217, 1958

Beta-propiolactone as a toxoiding agent. Nature. Lond., 182: 1216-1217, 1958

Beta-propiolactone as an agent for enzyme sterilization. Journal of Clinical Pathology 24(7): 658-660, 1971

The effect of beta-propiolactone on the scrapie agent. Journal of General Virology 3(2): 281-283, 1968

Use of beta-propiolactone as an inactivating agent for the preparation of vaccines against aphthous fever. Annales de l'Institut Pasteur 112(1): 65-76, 1967

Beta-propiolactone as a virus altering agent for a Newcastle disease vaccine. Poultry Sci 34(5): 1010-1013, 1955

Virucidal activity of beta-propiolactone vapor. I. Effect of beta-propiolactone vapor on Venezuelan equine encephalomyelitis virus. Applied Microbiology 7(4): 199-201, 1959

Safety of beta propiolactone uv treated ppsb factor ix concentrate. Thrombosis Research (Suppl. 7): 49, 1987